Strategic acquisition strengthens InSphero’s global position as the market leader in predictive in vitro modeling and high-content imaging servicesSCHLIEREN, Switzerland & SAN DIEGO--(BUSINESS WIRE)-- ...
IBS-related symptom prevalence in the region is among the highest in the world, reaching an average of 27% An ideal region uniquely positioned for CellTolerance®’s direct out-of-pocket commercial ...
Verdiva Bio Limited (“Verdiva Bio” or “the Company”), a clinical-stage biotechnology company advancing a scalable, once-weekly oral obesity product pipeline, today announced that two abstracts have ...
The collaboration brings together BMS’ deep scientific expertise and Anthropic's frontier AI to accelerate the discovery, development and delivery of transformational medicinesBMS will deploy Claude's ...
Engage Bio’s Tethosome platform is designed to improve the potency, tolerability, and redosability of non-viral DNAAcquisition combines Engage’s innovative platform with Lilly’s broad genetic ...
California workers’ compensation spending on Migraine Drugs continues to climb sharply as the use of new, high-cost Calcitonin Gene-Related Peptide (CGRP) targeted medications increases according to ...
Esteemed education program draws highly competitive applicant pool of practice owners, associates, and emerging dental leaders. IRVINE, CA / ACCESS Newswire / May 20, 2026 / Glidewell, America's ...
Americhem, a global leader in polymer solutions, today announced the launch of its High Performance Alloy (HPA) platform, ...
New peer-reviewed research published by ki:elements and the PROSPECT-AD consortium demonstrates that the company’s Speech Biomarker for Cognition (SB-C) can reliably detect cognitive impairment and ...
Participation Instructions for Jaguar Health Investor Webcast When: Tuesday, May 26, 2026 at 8:30 a.m. Eastern Participant Registration & Access Link: Click Here Replay: A replay of the webcast will ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and ...
CytoAgents, Inc., a clinical-stage biotechnology company at the forefront of immunologic research, today announced the ...